Ingrid W van der Cruijsen

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

Gerrit Draisma, Rob Boer, Suzie J. Otto et al. · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

Medicine, Preventive Medicine, Urology +16

Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

Suzie J. Otto, Ingrid W van der Cruijsen, Michael Liem et al. · International Journal of Cancer · 2003 · 84 citations · Full text

Medicine, Oncology, Urology +12

No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam)

Monique J. Roobol, Ingrid W van der Cruijsen, Fritz H. Schröder · Urology · 2004 · 20 citations

Medicine, Oncology, Urology +6

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening

Gerrit Draisma, Rob Boer, Suzie J. Otto et al. · 2003 · 14 citations

Medicine, Urology, Cancer Screening +13